LEVETIRACETAM | A215069 | SCIEGEN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.1645
per ea
Lowest NADAC/Unit
$0.0568
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 50228047360LEVETIRACETAM 1,000 MG TABLET | $0.1645 | EA | Generic | — | 2026-10-21 |
| 50228047212LEVETIRACETAM 750 MG TABLET | $0.1107 | EA | Generic | — | 2026-10-21 |
| 50228047205LEVETIRACETAM 750 MG TABLET | $0.1107 | EA | Generic | — | 2026-10-21 |
| 50228047112LEVETIRACETAM 500 MG TABLET | $0.0722 | EA | Generic | — | 2026-10-21 |
| 50228047105LEVETIRACETAM 500 MG TABLET | $0.0722 | EA | Generic | — | 2026-10-21 |
| 50228047005LEVETIRACETAM 250 MG TABLET | $0.0568 | EA | Generic | — | 2026-10-21 |
| 50228047012LEVETIRACETAM 250 MG TABLET | $0.0568 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.